powered by centersite dot net
Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
Health Tip: Rewarding Kids Without FoodDo Older Dads Produce Brainy Boys?USPSTF Concludes Screening for Obesity Beneficial for ChildrenFirearms Kill or Wound 7,000 U.S. Children AnnuallyGuns Kill or Wound 7,000 U.S. Kids a Year: ReportTime for Some Summer Sun Safety TipsHealth Tip: Applying Sunscreen on ChildrenMany Preemies Don't Struggle in SchoolHealth Tip: When Your Child Won't Eat LunchResearchers Target Zolmitriptan Dosing for Pediatric MigraineMigraine Warning Signs May Differ in Kids, AdultsHealth Tip: Keep Germs Out of Pool WaterWhen a Divorce Turns Bitter, Kids' Immune Systems May Pay a PriceBrush Up on Swim Safety for SummerLawn Mowers Are Risky Business for KidsAre All Those 'Fidget Spinners' Really Helping Kids?1 in 5 U.S. Kids Killed in Crashes Not Restrained ProperlyHelping Ease Kids' Fears After Manchester Terror AttackHealth Tip: Limit a Young Child's Media TimeMany Parents Underestimate Drowning RisksChildren Express Positive Views of Digital Tracking by StrangersToo Many Parents Say No to Helmets for Kids on WheelsHear This! Keep Cotton Swabs Out of Kids' EarsHealth Tip: Be a Safe Driver for Your Kids'Dr. Google' May Undermine Parents' Trust in Their PediatricianPAS: Hospitalizations Up for Suicidal Thoughts, Actions in KidsGuns Send About 16 U.S. Kids to the Hospital Every DayWhen Grandparents Raise Grandkids, Are They Up to Date on Child Safety?More Starring Roles for Booze in Kids' Movies, Study FindsThe Family That Eats Together, BenefitsAre Smartphones Helping or Harming Kids' Mental Health?More Active Kids Could Save U.S. Billions in Health Costs: StudyTrump Administration Rolls Back Obama-Era School Lunch RulesAre Bullies Getting Run Out of U.S. Schools?Health Tip: Turn Off Those ScreensKids' Sun Safety Means 'Slip, Slap, Slop'Pediatricians Missing Elevated Blood Lead Levels in U.S.AAP Stresses Medical Home Best for Acute Health ConcernsAre Kids' Vaccines a Victim of Their Own Success?Checklist for Family-Centered Rounds Deemed BeneficialChildren With Suspected Child Abuse Present to Hospital LateCancer Risk Rises After Childhood Organ Transplant: StudyModel Predicts Which Pediatric ER Patients Likely to Be AdmittedObesity Quadruples Kids' Type 2 Diabetes Risk: StudyAre You Raising an 'Emotional Eater'?Kids Face Their Own Death Risks When a Sibling DiesIn America's Poorest Communities, a Greater Risk of Child Abuse DeathsFDA Warns Against Children Taking Codeine, TramadolNext Seven Great Achievements in Pediatric Research PredictedDon't Give Kids Medicines With Codeine, Tramadol: FDA
Questions and AnswersVideosLinksBook Reviews
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Parenting
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)
Child Development & Parenting: Middle (8-11)
Child Development Theory: Adolescence (12-24)

Researchers Target Zolmitriptan Dosing for Pediatric Migraine


HealthDay News
Updated: Jun 8th 2017

new article illustration

THURSDAY, June 8, 2017 (HealthDay News) -- In a report published online June 5 in the Journal of Clinical Pharmacology, recommended dosing regimens of zolmitriptan are suggested for children with migraine.

Wangda Zhou, Ph.D., from AstraZeneca Pharmaceuticals in Waltham, Mass., and colleagues developed a population pharmacokinetic model for zolmitriptan and its active metabolite in adults and adolescents, and provided appropriate dosing regimens for use in clinical trials in 6- to 11-year-old children. Data from a single-dose study involving 5.0-mg zolmitriptan nasal spray (ZNS) conducted in adult and adolescents with migraine were applied.

The researchers found that adults and adolescents had similar plasma concentration profiles of zolmitriptan and its metabolite 183C91. The estimated typical apparent volume of distribution and clearance of zolmitriptan were 136 L and 121 L/h, respectively; between-subject variability was 56.5 and 42.6 percent, respectively. To achieve exposures similar to those of the adult and adolescent population administered 5.0 mg ZNS, a body-weight dosing scheme of 5.0 and 2.5 mg ZNS is recommended in children greater than and less than 50 kg, respectively.

"The recommended doses for children to achieve exposure similar to that observed in adults given 2.5 mg ZNS are 2.5 mg (≥50 kg) and 1.0 mg (15 to 50 kg)," the authors write. "These dosing regimens could be used in future clinical trials."

The authors disclosed financial ties to AstraZeneca, a manufacturer of zolmitriptan.

Abstract
Full Text (subscription or payment may be required)